496 related articles for article (PubMed ID: 8377827)
1. Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
Johnson DG; Schwarz JK; Cress WD; Nevins JR
Nature; 1993 Sep; 365(6444):349-52. PubMed ID: 8377827
[TBL] [Abstract][Full Text] [Related]
2. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
3. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
[TBL] [Abstract][Full Text] [Related]
4. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells.
Sala A; Nicolaides NC; Engelhard A; Bellon T; Lawe DC; Arnold A; Graña X; Giordano A; Calabretta B
Cancer Res; 1994 Mar; 54(6):1402-6. PubMed ID: 8137237
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
Shan B; Farmer AA; Lee WH
Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882
[TBL] [Abstract][Full Text] [Related]
6. The E2F1-3 transcription factors are essential for cellular proliferation.
Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G
Nature; 2001 Nov; 414(6862):457-62. PubMed ID: 11719808
[TBL] [Abstract][Full Text] [Related]
7. An E2F dominant negative mutant blocks E1A induced cell cycle progression.
Dobrowolski SF; Stacey DW; Harter ML; Stine JT; Hiebert SW
Oncogene; 1994 Sep; 9(9):2605-12. PubMed ID: 8058324
[TBL] [Abstract][Full Text] [Related]
8. A new component of the transcription factor DRTF1/E2F.
Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
10. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
[TBL] [Abstract][Full Text] [Related]
11. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Samara R; Espinoza LA; Hassa PO; Hottiger MO; Smulson ME
Oncogene; 2003 Nov; 22(52):8460-71. PubMed ID: 14627987
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
[TBL] [Abstract][Full Text] [Related]
13. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
15. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
Kastner A; Espanel X; Brun G
Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
[TBL] [Abstract][Full Text] [Related]
16. Caspase-dependent apoptosis by ectopic expression of E2F-4.
Chang YC; Nakajima H; Illenye S; Lee YS; Honjo N; Makiyama T; Fujiwara I; Mizuta N; Sawai K; Saida K; Mitsui Y; Heintz NH; Magae J
Oncogene; 2000 Sep; 19(41):4713-20. PubMed ID: 11032021
[TBL] [Abstract][Full Text] [Related]
17. Functional roles of E2F in cell cycle regulation.
Fan J; Bertino JR
Oncogene; 1997 Mar; 14(10):1191-200. PubMed ID: 9121768
[TBL] [Abstract][Full Text] [Related]
18. Proto-oncogenic properties of the DP family of proteins.
Jooss K; Lam EW; Bybee A; Girling R; Müller R; La Thangue NB
Oncogene; 1995 Apr; 10(8):1529-36. PubMed ID: 7731707
[TBL] [Abstract][Full Text] [Related]
19. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
Ohtani K; Iwanaga R; Nakamura M; Ikeda M; Yabuta N; Tsuruga H; Nojima H
Oncogene; 1999 Apr; 18(14):2299-309. PubMed ID: 10327050
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]